Cargando…
A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer
Prostate cancer (PCa) is a genetically heterogeneous cancer entity that causes challenges in pre-treatment clinical evaluation, such as the correct identification of the tumor stage. Conventional clinical tests based on digital rectal examination, Prostate-Specific Antigen (PSA) levels, and Gleason...
Autores principales: | Fischer, Sarah, Tahoun, Mohamed, Klaan, Bastian, Thierfelder, Kolja M., Weber, Marc-André, Krause, Bernd J., Hakenberg, Oliver, Fuellen, Georg, Hamed, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770738/ https://www.ncbi.nlm.nih.gov/pubmed/31480766 http://dx.doi.org/10.3390/cancers11091293 |
Ejemplares similares
-
Data-Driven Radiogenomic Approach for Deciphering Molecular Mechanisms Underlying Imaging Phenotypes in Lung Adenocarcinoma: A Pilot Study
por: Fischer, Sarah, et al.
Publicado: (2023) -
Entering an era of radiogenomics in prostate cancer risk stratification
por: Soodana-Prakash, Nachiketh, et al.
Publicado: (2018) -
Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021) -
Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022) -
Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer
por: Dinis Fernandes, Catarina, et al.
Publicado: (2023)